Becton, Dickinson and Company (BDX) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Instruments & Supplies secteur d'activité. Le siège social de l'entreprise est situé à Franklin Lakes, NJ, United States. Le PDG actuel est Thomas E. Polen Jr..
BDX a date d'introduction en bourse 1973-02-21, 70,000 employés à temps plein, cotée sur le NYSE, une capitalisation boursière de $56.34B.
Becton, Dickinson and Company is a global medical technology manufacturer founded in 1897 that develops and sells medical supplies, devices, laboratory equipment, and diagnostic products serving healthcare institutions, physicians, life science researchers, clinical laboratories, and pharmaceutical companies worldwide. The company operates through three primary segments: BD Medical, which provides infusion therapy systems, medication management solutions, and diabetes care products; BD Life Sciences, which offers blood collection, microbiology automation, and cellular analysis systems; and BD Interventional, which supplies surgical instruments, grafts, and critical care products. With headquarters in Franklin Lakes, New Jersey, the company delivers comprehensive solutions across medical device manufacturing, laboratory diagnostics, and clinical interventions.
